Mesenchymal chondrosarcoma
MONDO:0006853A morphologic variant of chondrosarcoma arising from bone and soft tissue. It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling. The clinical course is aggressive, with local recurrences and distant metastases.
Also known as: mesenchymal chondrosarcoma
2778 clinical trials for this condition and its sub-types, 4 tagged with Mesenchymal chondrosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Mesenchymal chondrosarcoma
-
Adult mesenchymal chondrosarcoma 0 trials
-
Pediatric mesenchymal chondrosarcoma 0 trials
-
New hope for rare bone cancer: trabectedin trial targets advanced disease
Disease control Recruiting nowThis study tests the drug trabectedin in 16 people aged 16 and older with advanced mesenchymal chondrosarcoma, a rare bone cancer that has spread or cannot be removed by surgery. Participants must have already tried at least one chemotherapy. The goal is to see if trabectedin can…
Phase 2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Scientists hunt for better ways to diagnose and treat rare bone tumors
Knowledge-focused Recruiting nowThis study looks at 300 people with cartilage tumors, including both benign types and the cancer chondrosarcoma. Researchers are studying genetic changes and molecules called miRNAs to better tell these tumors apart and predict outcomes. The goal is to improve diagnosis and find …
Sponsor: St. Anne's University Hospital Brno, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC